scholarly journals Impact of maternal obesity on offspring obesity and cardiometabolic disease risk

Reproduction ◽  
2010 ◽  
Vol 140 (3) ◽  
pp. 387-398 ◽  
Author(s):  
Amanda J Drake ◽  
Rebecca M Reynolds
Keyword(s):  
Maternal Obesity ◽  
Disease Risk ◽  
Vascular Dysfunction ◽  
Later Life ◽  
Adverse Outcomes ◽  
Cardiometabolic Health ◽  
Mother And Child ◽  
Prevalence Of Obesity ◽  
And Function

The prevalence of obesity among pregnant women is increasing. In addition to the short-term complications of obesity during pregnancy in both mother and child, it is now recognised that maternal obesity has long-term adverse outcomes for the health of her offspring in later life. Evidence from both animal and human studies indicates that maternal obesity increases the risk for the offspring in developing obesity and altering body composition in child- and adulthood and, additionally, it also has an impact on the offspring's cardiometabolic health with dysregulation of metabolism including glucose/insulin homoeostasis, and development of hypertension and vascular dysfunction. Potential mechanisms include effects on the development and function of adipose tissue, pancreas, muscle, liver, the vasculature and the brain. Further studies are required to elucidate the mechanisms underpinning the programming of disease risk in the offspring as a consequence of maternal obesity. The ultimate aim is to identify potential targets, which may be amenable to prevention or early intervention in order to improve the health of this and future generations.

scholarly journals Overweight and obesity in pregnancy: their impact on epigenetics

2021 ◽  
Author(s):  
Christoph Reichetzeder
Keyword(s):  
Clinical Studies ◽  
Maternal Obesity ◽  
Later Life ◽  
Overweight And Obesity ◽  
Cardiometabolic Disease ◽  
Mother And Child ◽  
Prevalence Of Obesity ◽  
Obesity In Pregnancy ◽  
And Function ◽  
In Pregnancy

AbstractOver the last few decades, the prevalence of obesity has risen to epidemic proportions worldwide. Consequently, the number of obesity in pregnancy has risen drastically. Gestational overweight and obesity are associated with impaired outcomes for mother and child. Furthermore, studies show that maternal obesity can lead to long-term consequences in the offspring, increasing the risk for obesity and cardiometabolic disease in later life. In addition to genetic mechanisms, mounting evidence demonstrates the induction of epigenetic alterations by maternal obesity, which can affect the offspring’s phenotype, thereby influencing the later risk of obesity and cardiometabolic disease. Clear evidence in this regard comes from various animal models of maternal obesity. Evidence derived from clinical studies remains limited. The current article gives an overview of pathophysiological changes associated with maternal obesity and their consequences on placental structure and function. Furthermore, a short excurse is given on epigenetic mechanisms and emerging data regarding a putative interaction between metabolism and epigenetics. Finally, a summary of important findings of animal and clinical studies investigating maternal obesity-related epigenetic effects is presented also addressing current limitations of clinical studies.

scholarly journals Endocrine-Disrupting Chemical Exposures in Pregnancy: a Sensitive Window for Later-Life Cardiometabolic Health in Women

2021 ◽  
Author(s):  
Emily S. Barrett ◽  
Susan W. Groth ◽  
Emma V. Preston ◽  
Carolyn Kinkade ◽  
Tamarra James-Todd
Keyword(s):  
Cardiovascular Disease ◽  
Maternal Obesity ◽  
Disease Risk ◽  
Cardiovascular Disease Risk ◽  
Later Life ◽  
Cardiometabolic Health ◽  
Endocrine Disrupting Chemical ◽  
Hypertensive Disorders ◽  
Endocrine Disrupting ◽  
In Pregnancy

Abstract Purpose of Review Pregnancy can be seen as a “stress test” with complications predicting later-life cardiovascular disease risk. Here, we review the growing epidemiological literature evaluating environmental endocrine-disrupting chemical (EDC) exposure in pregnancy in relation to two important cardiovascular disease risk factors, hypertensive disorders of pregnancy and maternal obesity. Recent Findings Overall, evidence of EDC-maternal cardiometabolic associations was mixed. The most consistent associations were observed for phenols and maternal obesity, as well as for perfluoroalkyl substances (PFASs) with hypertensive disorders. Research on polybrominated flame retardants and maternal cardiometabolic outcomes is limited, but suggestive. Summary Although numerous studies evaluated pregnancy outcomes, few evaluated the postpartum period or assessed chemical mixtures. Overall, there is a need to better understand whether pregnancy exposure to these chemicals could contribute to adverse cardiometabolic health outcomes in women, particularly given that cardiovascular disease is the leading cause of death in women.

scholarly journals Long term alterations of growth after antenatal steroids in preterm twin pregnancies

2020 ◽  
Vol 0 (0) ◽  
Author(s):  
Thorsten Braun ◽  
Vivien Filleböck ◽  
Boris Metze ◽  
Christoph Bührer ◽  
Andreas Plagemann ◽  
...  
Keyword(s):  
Early Childhood ◽  
Disease Risk ◽  
Later Life ◽  
Ponderal Index ◽  
Childhood Growth ◽  
Antenatal Steroids ◽  
Increased Risk ◽  
Infancy And Early Childhood ◽  
Twin Pregnancies

AbstractObjectivesTo compare the long-term effects of antenatal betamethasone (ANS, ≤16 mg, =24 mg and >24 mg) in twins on infant and childhood growth.MethodsA retrospective cohort follow up study among 198 twins after ANS including three time points: U1 first neonatal examination after birth and in the neonatal period; U7 examination from the 21st to the 24th month of life and U9 examination from the 60th to the 64th month of life using data from copies of the children’s examination booklets. Inclusion criteria are twin pregnancies with preterm labor, cervical shortening, preterm premature rupture of membranes, or vaginal bleeding, and exposure to ANS between 23+5 and 33+6 weeks. Outcome measures are dosage-dependent and sex-specific effects of ANS on growth (body weight, body length, head circumference, body mass index and ponderal index) up to 5.3 years.ResultsOverall, 99 live-born twin pairs were included. Negative effects of ANS on fetal growth persisted beyond birth, altered infant and childhood growth, independent of possible confounding factors. Overall weight percentile significantly decreased between infancy and early childhood by 18.8%. Birth weight percentiles significantly changed in a dose dependent and sex specific manner, most obviously in female-female and mixed pairs. The ponderal index significantly decreased up to 42.9%, BMI index increased by up to 33.8%.ConclusionsANS results in long-term alterations in infant and childhood growth. Changes between infancy and early childhood in ponderal mass index and BMI, independent of dose or twin pair structure, might indicate an ANS associated increased risk for later life disease.SynopsisFirst-time report on long-term ANS administration growth effects in twin pregnancies, showing persisting alterations beyond birth in infant and childhood growth up to 5.3 years as potential indicator of later life disease risk.

scholarly journals Maternal Obesity, Inflammation, and Developmental Programming

2014 ◽  
Vol 2014 ◽  
pp. 1-14 ◽  
Author(s):  
Stephanie A. Segovia ◽  
Mark H. Vickers ◽  
Clint Gray ◽  
Clare M. Reynolds
Keyword(s):  
Maternal Obesity ◽  
Later Life ◽  
Developmental Programming ◽  
Health Concern ◽  
Low Grade ◽  
Critical Periods ◽  
Omega 3 ◽  
Child Bearing ◽  
Prevalence Of Obesity ◽  
Low Grade Inflammation

The prevalence of obesity, especially in women of child-bearing age, is a global health concern. In addition to increasing the immediate risk of gestational complications, there is accumulating evidence that maternal obesity also has long-term consequences for the offspring. The concept of developmental programming describes the process in which an environmental stimulus, including altered nutrition, during critical periods of development can program alterations in organogenesis, tissue development, and metabolism, predisposing offspring to obesity and metabolic and cardiovascular disorders in later life. Although the mechanisms underpinning programming of metabolic disorders remain poorly defined, it has become increasingly clear that low-grade inflammation is associated with obesity and its comorbidities. This review will discuss maternal metainflammation as a mediator of programming in insulin sensitive tissues in offspring. Use of nutritional anti-inflammatories in pregnancy including omega 3 fatty acids, resveratrol, curcumin, and taurine may provide beneficial intervention strategies to ameliorate maternal obesity-induced programming.

Growing healthy muscles to optimise metabolic health into adult life

2014 ◽  
Vol 5 (6) ◽  
pp. 420-434 ◽  
Author(s):  
S. A. Bayol ◽  
C. R. Bruce ◽  
G. D. Wadley
Keyword(s):  
Skeletal Muscle ◽  
Muscle Development ◽  
Maternal Obesity ◽  
Adult Life ◽  
Metabolic Health ◽  
Skeletal Muscle Development ◽  
Pregnancy And Lactation ◽  
Functional Consequences ◽  
And Function

The importance of skeletal muscle for metabolic health and obesity prevention is gradually gaining recognition. As a result, interventions are being developed to increase or maintain muscle mass and metabolic function in adult and elderly populations. These interventions include exercise, hormonal and nutritional therapies. Nonetheless, growing evidence suggests that maternal malnutrition and obesity during pregnancy and lactation impede skeletal muscle development and growth in the offspring, with long-term functional consequences lasting into adult life. Here we review the role of skeletal muscle in health and obesity, providing an insight into how this tissue develops and discuss evidence that maternal obesity affects its development, growth and function into adult life. Such evidence warrants the need to develop early life interventions to optimise skeletal muscle development and growth in the offspring and thereby maximise metabolic health into adult life.

scholarly journals Impact of Maternal Obesity on Fetal Programming of Cardiovascular Disease

Physiology ◽  
2015 ◽  
Vol 30 (3) ◽  
pp. 224-231 ◽  
Author(s):  
Victoria H. J. Roberts ◽  
Antonio E. Frias ◽  
Kevin L. Grove
Keyword(s):  
Cardiovascular Disease ◽  
Health Risks ◽  
Fetal Programming ◽  
Maternal Obesity ◽  
Later Life ◽  
Epidemiological Studies ◽  
Cardiovascular Development ◽  
Mechanistic Studies ◽  
In Utero Environment

The in utero environment is a key determinant of long-term health outcomes; poor maternal metabolic state and placental insufficiency are strongly associated with these long-term health risks. Human epidemiological studies link maternal obesity and offspring cardiovascular disease in later life, but mechanistic studies in animal models are limited. Here, we review the literature pertaining to maternal consequences of obesity during pregnancy and the subsequent impact on fetal cardiovascular development.

The Gut Microbiota, Nutrition, and Long-Term Disease Risk: A Mother and Child Perspective

2021 ◽  
Author(s):  
Vanessa Montoya-Uribe ◽  
Natalija Glibetic ◽  
Femke J. Aan ◽  
Michelle L. Matter
Keyword(s):  
Gut Microbiota ◽  
Disease Risk ◽  
Child Perspective ◽  
Mother And Child

scholarly journals Intestinal microbiota during early life – impact on health and disease

2014 ◽  
Vol 73 (4) ◽  
pp. 457-469 ◽  
Author(s):  
Lotta Nylund ◽  
Reetta Satokari ◽  
Seppo Salminen ◽  
Willem M. de Vos
Keyword(s):  
Intestinal Microbiota ◽  
Early Life ◽  
Later Life ◽  
Related Factors ◽  
Life Impact ◽  
Health And Disease ◽  
And Function ◽  
The Impact

In the first years after birth, the intestinal microbiota develops rapidly both in diversity and complexity while being relatively stable in healthy adults. Different life-style-related factors as well as medical practices have an influence on the early-life intestinal colonisation. We address the impact of some of these factors on the consecutive microbiota development and later health. An overview is presented of the microbial colonisation steps and the role of the host in that process. Moreover, new early biomarkers are discussed with examples that include the association of microbiota and atopic diseases, the correlation of colic and early development and the impact of the use of antibiotics in early life. Our understanding of the development and function of the intestinal microbiota is constantly improving but the long-term influence of early-life microbiota on later life health deserves careful clinical studies.

The Birmingham Registry for Twin and Heritability Studies (BiRTHS)

2006 ◽  
Vol 9 (6) ◽  
pp. 907-912 ◽  
Author(s):  
Ruth E. Krone ◽  
Andrew K. Ewer ◽  
Timothy G. Barrett ◽  
Robert J. Moy ◽  
Shagaf Bakour ◽  
...  
Keyword(s):  
Fetal Growth ◽  
Maternal Obesity ◽  
Maternal Nutrition ◽  
Depression Scale ◽  
Postnatal Growth ◽  
Size Growth ◽  
Prevalence Of Obesity ◽  
Adults And Children ◽  
Prospective Study Design

AbstractIn this article we present the protocol of the Birmingham Registry for Twin Heritability Studies (BiRTHS), which aims to establish a long-term prospective twin registry with twins identified from the antenatal period and subjected to detailed follow-up. We plan to investigate the concordance in anthropo-metrics and early childhood phenotypes between 66 monozygotic and 154 dizygotic twin pairs in the first 2 years of recruitment. In this project we plan to determine the relative contributions of heritability and environment to fetal growth, birth size, growth in infancy and development up to 2 years of age in an ethnically mixed population. Twins will be assessed with the Griffitth's Mental Development Scales, which will enable us to obtain detailed information on development. As maternal depression may have an effect on the twins' neurodevelopment, the Edinburgh Postnatal Depression Scale will be used at various stages during pregnancy and after delivery to assess maternal depressive symptoms. The increasing prevalence of obesity in both adults and children has raised concerns about the effect of maternal obesity in pregnancy on fetal growth. The prospective study design gives us the opportunity to obtain data on maternal nutrition (reflected by body mass index) and ante- and postnatal growth and development of twins.

scholarly journals Epigenetic regulation of transcription: a mechanism for inducing variations in phenotype (fetal programming) by differences in nutrition during early life?

2007 ◽  
Vol 97 (6) ◽  
pp. 1036-1046 ◽  
Author(s):  
Graham C. Burdge ◽  
Mark A. Hanson ◽  
Jo L. Slater-Jefferies ◽  
Karen A. Lillycrop
Keyword(s):  
Epigenetic Regulation ◽  
Fetal Programming ◽  
Early Life ◽  
Disease Risk ◽  
Human Subjects ◽  
Covalent Modification ◽  
Regulation Of Transcription ◽  
Early Life Environment ◽  
And Function

There is considerable evidence for the induction of different phenotypes by variations in the early life environment, including nutrition, which in man is associated with a graded risk of metabolic disease; fetal programming. It is likely that the induction of persistent changes to tissue structure and function by differences in the early life environment involves life-long alterations to the regulation of gene transcription. This view is supported by both studies of human subjects and animal models. The mechanism which underlies such changes to gene expression is now beginning to be understood. In the present review we discuss the role of changes in the epigenetic regulation of transcription, specifically DNA methylation and covalent modification of histones, in the induction of an altered phenotype by nutritional constraint in early life. The demonstration of altered epigenetic regulation of genes in phenotype induction suggests the possibility of interventions to modify long-term disease risk associated with unbalanced nutrition in early life.

Sign in / Sign up

Export Citation Format

Share Document